Innovative, long-acting treatments – for patients and society
Camurus is committed to improving the lives of patients with severe and chronic diseases
Learn more
Delivering better treatments
Camurus is committed to improving the lives of patients with severe and chronic diseases
Learn more
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care.
Events
Upcoming events
-
03Nov
BIO Europe
Camurus will participate in this conference in Vienna, Austria, 3-5 November, 2025.
-
06Nov
Interim Report January-September 2025
The interim report January-September is published on 6 November 2025.
-
06Nov
Interim Report January-September 2025 – Webcast
Financial analysts, investors and media are invited to attend a webcast and presentation of the second quarter results at 2.00 pm CET.
Access the webcast using this link: Webcast
To participate in the presentation and ask questions, please register using the link below. After registering, please use the provided phone number and conference ID to dial in. Register to dial in
Latest financial report
Camurus’ Interim Report Second Quarter 2025
17 July 2025
Pipeline
Diversified pipeline with large potential
Camurus’ innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
sustainability
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
